A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a 'standard' dose of 150 IU/day in 'standard' patients undergoing IVF/ICSI treatment | Zendy

Biljana Popovic-Todorovic | Zendy

Open Access

A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a 'standard' dose of 150 IU/day in 'standard' patients undergoing IVF/ICSI treatment

Author(s) -

Biljana Popovic-Todorovic

Publication year - 2003

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/deg472

Subject(s) - medicine , regimen , ovarian hyperstimulation syndrome , randomized controlled trial , pregnancy rate , randomization , prospective cohort study , gynecology , clinical trial , ovulation induction , population , pregnancy , urology , ovulation , in vitro fertilisation , hormone , biology , environmental health , genetics

The study aim was to compare the use of individual rFSH doses between 100 and 250 IU/day (calculated using the rFSH dose normogram) with a standard dose of rFSH of 150 IU/day.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research